MedPath

Endometrial Evaluation in Cases of Postmenopausal Bleeding

Conditions
Postmenopausal Bleeding
Registration Number
NCT03847415
Lead Sponsor
Cairo University
Brief Summary

The aim of this prospective observational study is to evaluate abnormal uterine bleeding in postmenopausal women using 3D(dimensional) ultrasound assessment of endometrial volume .Doppler assessment of endometrium and hysteroscopy and to correlate this finding with pathological finding of endometrial biopsy

Detailed Description

Postmenopausal bleeding (PMB) is defined as vaginal bleeding occurring after twelve months of amenorrhoea, in a woman of the age where the menopause can be expected. Hence it does not apply to a young woman, who has had amenorrhoea from anorexia nervosa, or a pregnancy followed by lactation. However, it can apply to younger women following premature ovarian failure or premature menopause, Postmenopausal bleeding is a common problem representing 5% of all gynaecology outpatient attendances. postmenopausal bleeding is usually the first symptom of endometrial cancer and active intervention can lead to its early detection. So, there is need of a diagnostic tool with high accuracy for detection of endometrial pathology in most efficient and least invasive method possible.

Endometrial sampling is the gold standard for diagnosing abnormalities in the endometrial tissues ,however . There is a growing trend to use noninvasive procedures such as TVS, to measure the endometrial thickness, diagnose adenomyosis, endometrial polyps .Another important ability of 3D TVS is volume calculation using the Virtual Organ Computer-aided AnaLysis (VOCAL) even in irregularly shaped structures. This method has been demonstrated to be more accurate than 2D-volume estimation .

• Hysteroscopy has the advantage of directly visualizing the uterine cavity and the endometrium, allowing biopsy to be taken immediately from the suspected abnormality.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Women Age > 45 years
  • with postmenopausal uterine bleeding
Exclusion Criteria
  • Women with bleeding disorders or coagulopathy
  • women with cervical cancer or breast carcinoma .
  • history of tamoxifen intake
  • women with fibroid .

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
accuracy of 3d ultrasound in post menopausal bleeding6months

to evalute women with postmenpausal uterine bleeding using three dimensional ultrasound assessment of endometrial volume

Secondary Outcome Measures
NameTimeMethod
comparison between hysteroscopy and ultrasound in post menopausal bleeding6months

to compare hysteroscopy with ultrasound

© Copyright 2025. All Rights Reserved by MedPath